6767 Stock Overview
Wiltrom Co., Ltd. researches, develops, manufactures, and sells a range of implantable medical devices in Taiwan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Wiltrom Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$40.05 |
| 52 Week High | NT$50.00 |
| 52 Week Low | NT$32.60 |
| Beta | 0.54 |
| 1 Month Change | 5.95% |
| 3 Month Change | 12.18% |
| 1 Year Change | -1.96% |
| 3 Year Change | 13.62% |
| 5 Year Change | n/a |
| Change since IPO | 1.65% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6767 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | 1.0% | -4.3% | -5.7% |
| 1Y | -2.0% | 1.9% | 23.8% |
Return vs Industry: 6767 underperformed the TW Medical Equipment industry which returned 1.9% over the past year.
Return vs Market: 6767 underperformed the TW Market which returned 23.8% over the past year.
Price Volatility
| 6767 volatility | |
|---|---|
| 6767 Average Weekly Movement | 4.9% |
| Medical Equipment Industry Average Movement | 4.4% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.5% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6767 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6767's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | n/a | n/a | www.wiltrom.com.tw |
Wiltrom Co., Ltd. researches, develops, manufactures, and sells a range of implantable medical devices in Taiwan and internationally. The company’s products include spinal fixation systems, interbody fusion systems, bone graft substitutes, vertebral body augmentation systems, and vertebroplasty bone cement. Wiltrom Co., Ltd.
Wiltrom Co., Ltd. Fundamentals Summary
| 6767 fundamental statistics | |
|---|---|
| Market cap | NT$1.17b |
| Earnings (TTM) | NT$1.49m |
| Revenue (TTM) | NT$282.54m |
784.5x
P/E Ratio4.1x
P/S RatioIs 6767 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6767 income statement (TTM) | |
|---|---|
| Revenue | NT$282.54m |
| Cost of Revenue | NT$59.94m |
| Gross Profit | NT$222.60m |
| Other Expenses | NT$221.11m |
| Earnings | NT$1.49m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.051 |
| Gross Margin | 78.79% |
| Net Profit Margin | 0.53% |
| Debt/Equity Ratio | 20.8% |
How did 6767 perform over the long term?
See historical performance and comparison